Overview
FibriCheck is a medically certified (CE Class IIa and FDA-cleared) AI-driven health platform that converts standard smartphones into clinical-grade heart monitors. By utilizing Photoplethysmography (PPG) technology, the application captures blood volume changes through the device's camera and flash, which are then analyzed by proprietary deep learning algorithms to detect cardiac arrhythmias such as Atrial Fibrillation (AFib), Bradycardia, Tachycardia, and PVCs. In the 2026 market landscape, FibriCheck serves as a critical infrastructure layer for remote patient monitoring (RPM), effectively bridging the gap between episodic clinical visits and continuous cardiac care. Its technical architecture is designed for high-fidelity signal processing and seamless data orchestration between patients and healthcare providers. The platform's ability to provide actionable data with high sensitivity (96%+) and specificity (97%+) makes it a leading choice for stroke prevention programs and post-operative monitoring globally. By integrating AI-driven symptom correlation, it provides clinicians with a longitudinal view of heart health that traditional Holter monitors often miss due to their temporary nature.